HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1

被引:245
|
作者
Schoofs, Till [1 ]
Klein, Florian [1 ,2 ,3 ]
Braunschweig, Malte [1 ,4 ]
Kreider, Edward F. [5 ,6 ]
Feldmann, Anna [7 ]
Nogueira, Lilian [1 ]
Oliveira, Thiago [1 ]
Lorenzi, Julio C. C. [1 ]
Parrish, Erica H. [5 ,6 ]
Learn, Gerald H. [5 ,6 ]
West, Anthony P., Jr. [8 ]
Bjorkman, Pamela J. [8 ]
Schlesinger, Sarah J. [1 ]
Seaman, Michael S. [9 ]
Czartoski, Julie [10 ]
McElrath, M. Juliana [10 ]
Pfeifer, Nico [7 ]
Hahn, Beatrice H. [5 ,6 ]
Caskey, Marina [1 ]
Nussenzweig, Michel C. [1 ,11 ]
机构
[1] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA
[2] Univ Cologne, Ctr Mol Med Cologne, Lab Expt Immunol, D-50931 Cologne, Germany
[3] Univ Hosp Cologne, Ctr Integrated Oncol Cologne Bonn, Dept Internal Med, D-50937 Cologne, Germany
[4] Univ Freiburg, Hugstetter Str 55, D-79106 Freiburg, Germany
[5] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA
[6] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA
[7] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Campus E14, D-66123 Saarbrucken, Germany
[8] CALTECH, Dept Biol, Pasadena, CA 91125 USA
[9] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA
[10] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA
[11] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA
基金
欧洲研究理事会;
关键词
BROADLY NEUTRALIZING ANTIBODIES; GENETIC SEQUENCE DIVERSITY; 2-SAMPLE TESTS; HUMANIZED MICE; CD4; BINDING; VACCINE; MACAQUES; VIREMIA; IMMUNOTHERAPY; POPULATIONS;
D O I
10.1126/science.aaf0972
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
3BNC117 is a broad and potent neutralizing antibody to HIV-1 that targets the CD4 binding site on the viral envelope spike. When administered passively, this antibody can prevent infection in animal models and suppress viremia in HIV-1-infected individuals. Here we report that HIV-1 immunotherapy with a single injection of 3BNC117 affects host antibody responses in viremic individuals. In comparison to untreated controls that showed little change in their neutralizing activity over a 6-month period, 3BNC117 infusion significantly improved neutralizing responses to heterologous tier 2 viruses in nearly all study participants. We conclude that 3BNC117-mediated immunotherapy enhances host humoral immunity to HIV-1.
引用
收藏
页码:997 / 1001
页数:5
相关论文
共 50 条
  • [1] HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
    Johannes F. Scheid
    Joshua A. Horwitz
    Yotam Bar-On
    Edward F. Kreider
    Ching-Lan Lu
    Julio C. C. Lorenzi
    Anna Feldmann
    Malte Braunschweig
    Lilian Nogueira
    Thiago Oliveira
    Irina Shimeliovich
    Roshni Patel
    Leah Burke
    Yehuda Z. Cohen
    Sonya Hadrigan
    Allison Settler
    Maggi Witmer-Pack
    Anthony P. West, Jr.
    Boris Juelg
    Tibor Keler
    Thomas Hawthorne
    Barry Zingman
    Roy M. Gulick
    Nico Pfeifer
    Gerald H. Learn
    Michael S. Seaman
    Pamela J. Bjorkman
    Florian Klein
    Sarah J. Schlesinger
    Bruce D. Walker
    Beatrice H. Hahn
    Michel C. Nussenzweig
    Marina Caskey
    [J]. Nature, 2016, 535 : 556 - 560
  • [2] HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
    Scheid, Johannes F.
    Horwitz, Joshua A.
    Bar-On, Yotam
    Kreider, Edward F.
    Lu, Ching-Lan
    Lorenzi, Julio C. C.
    Feldmann, Anna
    Braunschweig, Malte
    Nogueira, Lilian
    Oliveira, Thiago
    Shimeliovich, Irina
    Patel, Roshni
    Burke, Leah
    Cohen, Yehuda Z.
    Hadrigan, Sonya
    Settler, Allison
    Witmer-Pack, Maggi
    West, Anthony P., Jr.
    Juelg, Boris
    Keler, Tibor
    Hawthorne, Thomas
    Zingman, Barry
    Gulick, Roy M.
    Pfeifer, Nico
    Learn, Gerald H.
    Seaman, Michael S.
    Bjorkman, Pamela J.
    Klein, Florian
    Schlesinger, Sarah J.
    Walker, Bruce D.
    Hahn, Beatrice H.
    Nussenzweig, Michel C.
    Caskey, Marina
    [J]. NATURE, 2016, 535 (7613) : 556 - +
  • [3] Focus on the therapeutic efficacy of 3BNC117 against HIV-1: In vitro studies, in vivo studies, clinical trials and challenges
    Liu, Zhi-Jun
    Bai, Jing
    Liu, Feng-Li
    Zhang, Xiang-Yang
    Wang, Jing-Zhang
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 52 : 44 - 50
  • [4] Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure
    Umotoy, Jeffrey C.
    de Taeye, Steven W.
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [5] Combination of HIV-1 Antibodies 3BNC117 and 10-1074 Delays Viral Rebound During Treatment Interruption
    Mendoza, Pilar
    Gruell, Henning
    Lu, Ching-Lan
    Butler, Allison
    Pai, Joy
    Nogueira, Lilian
    Oliveira, Thiago Y.
    Lorenzi, Julio C. C.
    Cohen, Yehuda Z.
    Millard, Katrina
    Unson-O'Brien, Cecille
    Belblidia, Shiraz A.
    Patel, Roshni
    Witmer-Pack, Maggi
    Schimeliovich, Irina
    Jankovic, Mila
    Seaman, Michael S.
    Klein, Florian
    Caskey, Marina
    Nussenzweig, Michel C.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 34 - 34
  • [6] Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
    Caskey, Marina
    Klein, Florian
    Lorenzi, Julio C. C.
    Seaman, Michael S.
    West, Anthony P., Jr.
    Buckley, Noreen
    Kremer, Gisela
    Nogueira, Lilian
    Braunschweig, Malte
    Scheid, Johannes F.
    Horwitz, Joshua A.
    Shimeliovich, Irina
    Ben-Avraham, Sivan
    Witmer-Pack, Maggi
    Platten, Martin
    Lehmann, Clara
    Burke, Leah A.
    Hawthorne, Thomas
    Gorelick, Robert J.
    Walker, Bruce D.
    Keler, Tibor
    Gulick, Roy M.
    Faetkenheuer, Gerd
    Schlesinger, Sarah J.
    Nussenzweig, Michel C.
    [J]. NATURE, 2015, 522 (7557) : 487 - +
  • [7] Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
    Marina Caskey
    Florian Klein
    Julio C. C. Lorenzi
    Michael S. Seaman
    Anthony P. West
    Noreen Buckley
    Gisela Kremer
    Lilian Nogueira
    Malte Braunschweig
    Johannes F. Scheid
    Joshua A. Horwitz
    Irina Shimeliovich
    Sivan Ben-Avraham
    Maggi Witmer-Pack
    Martin Platten
    Clara Lehmann
    Leah A. Burke
    Thomas Hawthorne
    Robert J. Gorelick
    Bruce D. Walker
    Tibor Keler
    Roy M. Gulick
    Gerd Fätkenheuer
    Sarah J. Schlesinger
    Michel C. Nussenzweig
    [J]. Nature, 2015, 522 : 487 - 491
  • [8] Facilitated DNA injection elicits specific immune responses to HIV-1
    McCallus, DE
    Coney, LR
    Pachuk, C
    Herold, K
    Higgins, T
    Carrano, R
    Ciccarelli, RB
    Ugen, KE
    Wang, B
    Boyer, J
    Weiner, DB
    [J]. VACCINES 96 - MOLECULAR APPROACHES TO THE CONTROL OF INFECTIOUS DISEASES, 1996, : 55 - 60
  • [9] Antibody responses to HIV-1 antigens are higher in HIV-1(+) intravenous drug users than in HIV-1(+) homosexuals
    Jiang, JD
    Bekesi, GJ
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2001, 55 (06) : 313 - 315
  • [10] The Antibody Response against HIV-1
    Overbaugh, Julie
    Morris, Lynn
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (01):